45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
5,358
Insurances with rates
1
CPT / HCPCS codes
3,833
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9029 | NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION | $240,050 | $120,025 | — | — | 4 |
| J9347 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION | $162,352 | $81,176 | — | — | 4 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $142,085 | $71,042 | — | — | 2 |
| J9269 | TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION | $135,077 | $67,538 | — | — | 2 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $111,116 | $55,558 | — | — | 2 |
| J9118 | CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION | $100,183 | $50,091 | — | — | 2 |
| C9399 | ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION | $95,050 | $47,525 | — | — | 6 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $91,682 | $45,841 | — | — | 2 |
| J9281 | MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT | $88,490 | $44,245 | — | — | 4 |
| J9274 | TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION | $81,970 | $40,985 | — | — | 2 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $74,456 | $37,228 | — | — | 2 |
| J0717 | CERTOLIZUMAB PEGOL 400 MG/2 ML (200 MG/ML X2) SUBCUTANEOUS SYRINGE KIT | $65,609 | $32,805 | — | — | 4 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $60,528 | $30,264 | — | — | 2 |
| J9307 | PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION | $58,741 | $29,371 | — | — | 4 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $57,485 | $28,742 | — | — | 4 |
| J1323 | ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION | $52,253 | $26,126 | — | — | 8 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $48,850 | $24,425 | — | — | 2 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $47,228 | $23,614 | — | — | 2 |
| J9119 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $42,477 | $21,239 | — | — | 2 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $42,126 | $21,063 | — | — | 2 |
| J9203 | GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN | $40,230 | $20,115 | — | — | 2 |
| J9316 | PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONID-ZZXF/10 ML SUBCUT SOLN | $37,159 | $18,580 | — | — | 2 |
| J9153 | DAUNORUBICIN 44 MG AND CYTARABINE 100 MG IN LIPOSOME IV SOLUTION | $36,150 | $18,075 | — | — | 6 |
| J9301 | OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION | $34,501 | $17,250 | — | — | 2 |
| J9223 | LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION | $32,490 | $16,245 | — | — | 2 |
| J9022 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION | $31,555 | $15,778 | — | — | 2 |
| J9311 | RITUXIMAB 1,600 MG/13.4 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN | $30,114 | $15,057 | — | — | 2 |
| J9273 | TISOTUMAB VEDOTIN-TFTV 40 MG INTRAVENOUS SOLUTION | $28,542 | $14,271 | — | — | 2 |
| J9303 | PANITUMUMAB 400 MG/20 ML (20 MG/ML) INTRAVENOUS SOLUTION | $28,164 | $14,082 | — | — | 2 |
| J9306 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION | $27,332 | $13,666 | — | — | 2 |
| J1299 | ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION | $26,142 | $13,071 | — | — | 2 |
| C1604 | SYSTEM CAP FOR ANY NUMBER OF TORUS STENT GRAFTS AND ENDOCROSS DEVICE DETOUR | $25,000 | $12,500 | — | — | 2 |
| J9271 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION | $23,178 | $11,589 | — | — | 6 |
| J9039 | BLINATUMOMAB 35 MCG INTRAVENOUS KIT | $22,275 | $11,137 | — | — | 2 |
| C1822 | KIT IPG INCLUDES STIM UNIT LEADS ETC | $21,500 | $10,750 | — | — | 2 |
| J9021 | ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION | $20,983 | $10,492 | — | — | 4 |
| J9015 | ALDESLEUKIN 22 MILLION UNIT INTRAVENOUS SOLUTION | $20,588 | $10,294 | — | — | 2 |
| J9057 | COPANLISIB 60 MG INTRAVENOUS SOLUTION | $20,248 | $10,124 | — | — | 2 |
| C1767 | GENERATOR NEUROSTIMULATOR L1.95 IN X H2.19 IN THK1.34 CM 25.5-MA 2-1200HZ 30.4 CU CM 5 IMPLANTABLE P | $19,500 | $9,750 | — | — | 2 |
| J9312 | RITUXIMAB 10 MG/ML CONCENTRATE,INTRAVENOUS | $18,840 | $9,420 | — | — | 4 |
| J9204 | MOGAMULIZUMAB-KPKC 4 MG/ML INTRAVENOUS SOLUTION | $18,805 | $9,402 | — | — | 2 |
| J9356 | TRASTUZUMAB 600 MG-HYALURONIDASE-OYSK 10,000 UNIT/5 ML SUBCUT SOLUTION | $18,751 | $9,376 | — | — | 2 |
| C1722 | DEFIBRILLATOR EMBLEM 130 GM D12.7 MM W83.1 MM X H69.1 MM CARDIAC | $18,000 | $9,000 | — | — | 2 |
| J0480 | BASILIXIMAB 20 MG INTRAVENOUS SOLUTION | $16,910 | $8,455 | — | — | 2 |
| J9177 | ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION | $16,904 | $8,452 | — | — | 2 |
| J9173 | DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION | $16,892 | $8,446 | — | — | 4 |
| J9354 | ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION | $16,009 | $8,004 | — | — | 2 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 30 MG INTRAVENOUS SOLUTION | $16,003 | $8,001 | — | — | 2 |
| J7520 | SIROLIMUS 1 MG/ML ORAL SOLUTION | $15,516 | $7,758 | — | — | 5 |
| J9061 | AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION | $15,277 | $7,638 | — | — | 4 |
Showing top 50 of 5,358 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.